The detection of androstenedione abuse in sport: A mass spectrometry strategy to identify the 4-hydroxyandrostenedione metabolite

Rapid Communications in Mass Spectrometry

Volumn 22, Issue 24, 2008, Pages 4147-4157

  Cawley, Adam T ^a,b   Trout, Graham J ^a   Kazlauskas, Rymantas ^a   George, Adrian V ^b  

^a NATIONAL MEASUREMENT INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; GAS CHROMATOGRAPHY; HYDROXYLATION; MASS SPECTROMETRY; PHYSIOLOGY;

C CONTENTS; GAS CHROMATOGRAPHY COMBUSTION-ISOTOPE RATIO MASS SPECTROMETRY; GASCHROMATOGRAPHY-MASS SPECTROMETRY; GLUCURONIDES; HYDROXYLATED METABOLITES; MASS SPECTROMETRY STRATEGIES; METABOLIC PATHWAYS; SPECIFIC DETECTION; TESTOSTERONE; URINARY EXCRETION;

METABOLITES;

EID: 60149104105     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.3826     Document Type: Article

References (29)

1. Gower DB, Fotherby K. In Biochemistry of Steroid Hormones, Makin HLJ (ed). Blackwell Scientific Publications: London, 1975; 77.
2. Uralets VP, Gillette PA. J. Anal. Toxicol. 1999; 23: 357.
3. WADA Technical Document, TD2004EAAS. Available: http://www.wada-ama.org/ rtecontent/document/end-steroids-aug-04.pdf (accessed 2/10/2006).
4. Cawley AT, Flenker U. J. Mass Spectrom. 2008; 43: 854.
5. Lévesque J-F, Ayotte C. In Recent Advances in Doping Analysis, vol. 7, Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds). Sport und Buch Straub: Köln, 1999; 169.
6. Development of reference ranges for blood and urine parameters in elite athletes. Australian Institute of Sport Ethics Committee: Canberra ACT, Australia (Approval date 21/9/1999).
7. Olympic Movement Anti-Doping Code, International Olympic Committee 1999. Available: http://multimedia.olympic.org/pdf/en-report-21.pdf (accessed July 2003).
8. Ward RJ, Shackleton CHL, Lawson AM. Br. J. Sports Med. 1975; 9: 93.
9. Masse R, Ayotte C, Dugal R. J. Chromatogr. 1989; 489: 23.
10. Cawley AT, Hine ER, Trout GJ, George AV, Kazlauskas R. Forensic Sci. Int. 2004; 143: 103.
11. Cawley AT, Kazlauskas R, Trout GJ, Rogerson JH, George AV. J. Chromatogr. Sci. 2005; 43: 32.
12. Gower DB, Houghton E, Kicman AT. In Steroid Analysis, Makin HLJ, Gower DB, Kirk DN (eds). Blackie Academic and Professional: London, 1995; 505.
13. Identification criteria for qualitative assays - incorporating mass spectrometry and chromatography. WADA Technical Document TD2003IDCR, World Anti-Doping Agency. Available: http://www.wada-ama.org/rtecontent/document/ criteria-1-2.pdf (accessed 8/2/2004).
14. Poon GK, Jarman M, Rowlands MG, Dowsett M, Firth J. J. Chromatogr. 1991; 565: 75.
15. Kohler M, Parr MK, Opfermann G, Thevis M, Schlörer N, Marner F-J, Schänzer W. Steroids 2007; 72: 278.
16. Tökés L, LaLonde RT, Djerassi C. J. Org. Chem. 1967; 32: 1012.
17. Van de Kerkhof DH. Steroid profiling in doping analysis. PhD thesis, Utrecht University, Utrecht, 2001; 139.
18. Spink DC, Spink BC, Zhou X, Hussain MM, Gierthy JF, Ding X. J. Steroid Biochem. Mol. Biol. 2000; 74: 11.
19. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. Proc. Natl. Acad. Sci. 1996; 93: 9776.
20. Abul-Hajj YJ. J. Steroid Biochem. 1980; 13: 1395.
21. Abul-Hajj YJ. J. Med. Chem. 1986; 29: 582.
22. Goss PE, Powles TJ, Dowsett M, Hutchison G, Brodie AM, Gazet JC, Coombes RC. Cancer Res. 1986; 46: 4823.
23. Dowsett M, Goss PE, Powles TJ, Hutchinson G, Brodie AM, Jeffcoate SL, Coombes RC. Cancer Res. 1987; 47: 1957.
24. Brodie AM, Schwarzel WC, Shaikh AA, Brodie HJ. Endocrinology 1977; 100: 1684.
25. Degen PH, Schneider W. J. Chromatogr.: Biomed. Appl. 1991; 565: 67.
26. The World Anti-Doping Agency (WADA) 2008 Prohibited List. Available: http://www.wada-ama.org/rtecontent/document/2008-List-En.pdf (accessed 15/1/08).
27. Mazzarino M, Botrè F. Rapid Commun. Mass Spectrom. 2006; 20: 3465.
28. Cawley AT, Kazlauskas R, Trout GJ, George AV, Silk AJ, Marshall-Gradisnik S, Weatherby R. Chem. Aust. 2006; 73: 3.
29. Lévesque J-F, Gaudreault M, Aubin Y, Chauret N. Steroids 2005; 70: 305.